Alcyone Therapeutics Inc., a clinical-stage biotechnology company pioneering next-generation precision genetic therapies and precision delivery solutions of therapies for complex neurological conditions, has officially...
BioVaxys Technology Corp, a clinical-stage biopharmaceutical company developing a portfolio of immune-educating therapies based on its novel DPX™ platform, has officially signed a Letter...
The Lung Cancer Research Foundation (LCRF), in collaboration with 23andMe Holding Co. and 20 lung cancer advocacy organizations, has officially announced a study, which...
Invitae, a leading medical genetics company, has officially announced the launch of its Unlock™ Behind the Seizure® program, which is designed to provide you...
Personify Health, the first and only platform company to bring health, wellbeing, and navigation solutions together, has officially published results of its new independent...
Immorna Biotherapeutics, Inc a, clinical stage biotechnology company developing both self-replicating and conventional mRNA-based therapeutics and vaccines, has officially secured FDA's approval for its...
Serac Healthcare Limited, a clinical radiopharmaceutical company developing an innovative molecular imaging agent, has officially secured FDA's Fast Track Designation for its 99mTc-maraciclatide as...
The U.S. Food and Drug Administration (FDA) has officially approved Eli Lily's Kisunla™ therapeutic, which is essentially presented as a treatment for Alzheimer’s in...
Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has officially announced the launch of a brand-new all-encompassing...
Neurolief, a leading developer of innovative brain neuromodulation technologies, has officially announced groundbreaking topline results from its pivotal clinical trial, which studied the efficacy...
Active Minds, along with higher ed virtual health provider, TimelyCare, has officially published a new set of findings, findings which focus on the close...
